Vivodyne Raises $40M to Replace Animal Testing in Drug Trials
29 May 2025 //
BUSINESSWIRE
Vivodyne Appoints Julie O`Shaughnessy as Chief Operating Officer
07 May 2024 //
BUSINESSWIRE
Vivodyne Announces $38 Million Seed Financing
22 Nov 2023 //
BUSINESSWIRE

Market Place
Sourcing Support